Filing Flows › Neuroone Medical Technologies (NMTC) › Stock forecast & fair value
Neuroone Medical Technologies (NMTC) stock forecast and price target
Neuroone Medical Technologies (NMTC) trades at $0.88. 3 analysts' median price target is $8.00 (+810%), from $5.00 to $8.80.
Neuroone Medical Technologies' latest quarter
Neuroone Medical Technologies, Q3 FY26: revenue $2.0M (+16% year over year), operating margin -122.9%, net loss $2.0M, operating cash flow −$1.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for NMTC stock?
The median of 3 analysts' 12-month targets is $8.00, +810% from $0.88; the range is $5.00 to $8.80. The average rating is none.
Does Neuroone Medical Technologies usually beat earnings estimates?
It beat the consensus EPS estimate in 33% of the quarters on record.
Is NMTC stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.